Disposable Syringes Market Report by Product Type (Conventional Syringes, Safety Syringes), Application (Immunization Injections, Therapeutic Injections), End User (Hospitals, Diagnostic Laboratories, and Others), and Region 2024-2032
세계의 일회용 주사기 시장 규모는 2023년 151억 달러에 달했습니다. 향후 IMARC 그룹은 시장이 2032년까지 274억 달러에 이를 전망이며, 2024년과 2032년 사이에 6.7%의 복합 연간 성장률(CAGR)을 나타낼 것으로 예측했습니다.
일회용 주사기는 다양한 질병을 치료하기 위해 정맥 내 또는 근육 내 주사에 널리 사용됩니다. 일회용 주사기는 의료, 수의학, R&D 분야에서 일회용으로 설계된 플라스틱 주사기입니다. 기존의 주사기에 비해 유지비가 들지 않고 저렴합니다. 교차 오염의 가능성을 줄이면서 환자의 안전을 유지하는 데 도움이 됩니다.
일회용 주사기 시장 동향 :
현재 심장병, 암, 뇌졸중, 호흡기 질환, 부상, 당뇨병, 알츠하이머병, 인플루엔자, 폐렴 등 다양한 만성 질환의 진단과 치료를 지원하기 위해 일회용 주사기의 사용이 증가하고 있습니다. 이것은 세계의 수술 건수 증가와 함께 시장을 견인하는 중요한 요인 중 하나가 되고 있습니다. 게다가 전염성이 없는 성적 접촉이나 감염된 혈액과의 접촉으로 인해 후천성 면역결핍 증후군(AIDS)을 앓고 있는 환자가 세계적으로 증가하고 있습니다. 이것은 급성장하는 건강 관리 산업과 함께 시장 성장을 뒷받침합니다. 이 외에도 주요 시장 관계자들은 특히 코로나바이러스 감염(COVID-19)의 유행 이후 건강 관리 종사자와 환자 간 감염을 피하면서 효율적인 멸균 수술에 주력하고 있습니다. 또한, 환자들 사이에서 바늘 찌르기 손상이 증가하는 것은 일회용 주사기 수요를 자극합니다. 이에 더해, 자가주사제의 동향 증가는 업계 투자자들에게 유리한 성장 기회를 제공합니다. 이 외에도 일부 국가의 정부는 수술실에서의 감염 확대를 방지하기 위해 일회용 의료 용품의 채택을 장려하기 위해 노력하고 있습니다. 이러한 노력은 향후 수년간 시장 성장을 뒷받침할 것으로 예측됩니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사의 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 일회용 주사기 시장
- 시장 개요
- 시장 실적
- COVID-19의 영향
- 시장 예측
제6장 시장 내역 : 제품 유형별
제7장 시장 분석 : 용도별
제8장 시장 분석 : 최종사용자별
제9장 시장 분석 : 지역별
- 북미
- 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 라틴아메리카
- 중동 및 아프리카
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
- 개요
- 구매자의 협상력
- 공급기업의 협상력
- 경쟁도
- 신규 참가업체의 위협
- 대체품의 위협
제13장 가격 분석
제14장 경쟁 구도
- 시장 구조
- 주요 기업
- 주요 기업 프로파일
- B. Braun Melsungen AG
- Baxter International Inc.
- Becton Dickinson and Company
- Cardinal Health Inc.
- Fresenius SE & Co. KGaA
- Henke-Sass Wolf GmbH
- Nipro Corporation
- Novo Nordisk A/S
- Retractable Technologies Inc.
- Terumo Corporation
- Vita Needle Company
BJH
The global disposable syringes market size reached US$ 15.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 27.4 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032.
Disposable syringes are widely utilized for injecting medicines through intravenous or intramuscular ways to treat different diseases. They are plastic syringes designed for one-time use in the medical, veterinary, and research and development (R&D) fields. They are cheaper compared to traditional syringes without any maintenance costs. They assist in maintaining the safety of the patients while reducing the chances of cross-contamination.
Disposable Syringes Market Trends:
At present, there is a rise in the use of disposable syringes to support the diagnosis and treatment of various chronic diseases, such as heart disease, cancer, stroke, respiratory disease, injuries, diabetes, Alzheimer's disease, influenza, and pneumonia. This, along with the growing number of surgeries across the globe, represents one of the key factors driving the market. In addition, there is an increase in the number of patients suffering from acquired immune deficiency syndrome (AIDS) around the world due to unprotected sexual contact and contact with infected blood. This, coupled with the burgeoning healthcare industry, is propelling the growth of the market. Besides this, key market players are focusing on efficient sterilizing surgery while avoiding infections among healthcare practitioners and patients, especially after the outbreak of the coronavirus disease (COVID-19) pandemic. Moreover, the growing incidences of needlestick injuries among patients are catalyzing the demand for disposable syringes. Besides this, the rising trend of self-injecting medicines is offering lucrative growth opportunities to industry investors. Apart from this, governments of several countries are undertaking initiatives to encourage the adoption of disposable medical supplies for preventing the spread of infections in operating rooms. These initiatives are projected to bolster the growth of the market in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global disposable syringes market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, application, and end user.
Breakup by Product Type:
Conventional Syringes
Safety Syringes
Retractable Safety Syringes
Non-Retractable Safety Syringes
Breakup by Application:
Immunization Injections
Therapeutic Injections
Breakup by End User:
Hospitals
Diagnostic Laboratories
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Cardinal Health Inc., Fresenius SE & Co. KGaA, Henke-Sass Wolf GmbH, Nipro Corporation, Novo Nordisk A/S, Retractable Technologies Inc., Terumo Corporation and Vita Needle Company.
Key Questions Answered in This Report:
- How has the global disposable syringes market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global disposable syringes market?
- What are the key regional markets?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global disposable syringes market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Disposable Syringes Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Conventional Syringes
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Safety Syringes
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Retractable Safety Syringes
- 6.2.2.2 Non-Retractable Safety Syringes
- 6.2.3 Market Forecast
7 Market Breakup by Application
- 7.1 Immunization Injections
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Therapeutic Injections
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Diagnostic Laboratories
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 B. Braun Melsungen AG
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 SWOT Analysis
- 14.3.2 Baxter International Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.3 Becton Dickinson and Company
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Cardinal Health Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Fresenius SE & Co. KGaA
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Henke-Sass Wolf GmbH
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Nipro Corporation
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Novo Nordisk A/S
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Retractable Technologies Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.10 Terumo Corporation
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Vita Needle Company
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
